Massachusetts Financial Services’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-28,866
Closed -$837K 876
2024
Q2
$837K Sell
28,866
-48,176
-63% -$2.29M ﹤0.01% 806
2024
Q1
$3.44M Buy
77,042
+9,308
+14% +$399K ﹤0.01% 697
2023
Q4
$2.63M Sell
67,734
-426
-0.6% -$15.3K ﹤0.01% 706
2023
Q3
$2M Sell
68,160
-501
-0.7% -$23.8K ﹤0.01% 719
2023
Q2
$4.37M Sell
68,661
-909
-1% -$50.3K ﹤0.01% 654
2023
Q1
$3.28M Buy
69,570
+5,144
+8% +$275K ﹤0.01% 671
2022
Q4
$4.47M Buy
64,426
+11,431
+22% +$1.14M ﹤0.01% 659
2022
Q3
$7.77M Buy
52,995
+3,590
+7% +$486K ﹤0.01% 628
2022
Q2
$6.44M Sell
49,405
-372
-0.7% -$38K ﹤0.01% 638
2022
Q1
$5.03M Buy
49,777
+1,374
+3% +$166K ﹤0.01% 676
2021
Q4
$7.49M Sell
48,403
-357
-0.7% -$79.6K ﹤0.01% 682
2021
Q3
$14.4M Sell
48,760
-636
-1% -$191K ﹤0.01% 644
2021
Q2
$16M Buy
+49,396
New +$16.2M ﹤0.01% 639

Other funds holding LYEL